Turcio-García, L. Á., Parra-Unda, R., Valdés, H., Hernández-Ortega, S., Valenzuela-Ramirez, G. G., Ahumada-Santos, Y. P., . . . Morales-Morales, D. (2025). Fluorinated Rh(I)–NHC Compounds as Potential Antibacterials Against Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates Producing ESBL. Pharmaceutics, 17(8), 973. https://doi.org/10.3390/pharmaceutics17080973
Chicago Style (17th ed.) CitationTurcio-García, Luis Ángel, Ricardo Parra-Unda, Hugo Valdés, Simón Hernández-Ortega, Gladymar Guadalupe Valenzuela-Ramirez, Yesmi Patricia Ahumada-Santos, Yesenia Sánchez-Lugo, Viviana Reyes-Márquez, and David Morales-Morales. "Fluorinated Rh(I)–NHC Compounds as Potential Antibacterials Against Multidrug-Resistant Klebsiella Pneumoniae Clinical Isolates Producing ESBL." Pharmaceutics 17, no. 8 (2025): 973. https://doi.org/10.3390/pharmaceutics17080973.
MLA (9th ed.) CitationTurcio-García, Luis Ángel, et al. "Fluorinated Rh(I)–NHC Compounds as Potential Antibacterials Against Multidrug-Resistant Klebsiella Pneumoniae Clinical Isolates Producing ESBL." Pharmaceutics, vol. 17, no. 8, 2025, p. 973, https://doi.org/10.3390/pharmaceutics17080973.